SCHEMBL2603673

SCHEMBL2603673

CNC(=O)Nc1cccc(Oc2ccnc3[nH]c(=O)oc23)c1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BRAF P15056 16/20 0.47
GCK P35557 3/20 0.46
PDGFRA P16234 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2603675 0.89 MEN1 (0.46) BRAF
SCHEMBL12615718 0.89 BRAF (0.45) BRAFPDGFRA
SCHEMBL13610570 0.87 BRAF (0.46) BRAFPDGFRA
SCHEMBL12616401 0.87 BRAF (0.44) BRAF
SCHEMBL12616754 0.85 BRAF (0.47) BRAF
SCHEMBL2603635 0.83 BRAF (0.46) BRAFGCK
SCHEMBL2603895 0.81 JAK1 (0.43) BRAF
SCHEMBL12652265 0.80 LYN (0.43) BRAF
SCHEMBL12615873 0.78 MAP2K1 (0.39) BRAF
SCHEMBL1796270 0.78 AURKA (0.40) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013207-B1 IMIDAZO[4,5-B]PYRIDIN-2-ONE COMPOUNDS AND ANALOGS THEREOF AS CANCER THERAPEUTIC COMPOUNDS CANCER REC TECH LTD (GB) 2012-04-25 EP disclosed